Objective High-density lipoprotein cholesterol (HDL-C) 
Introduction

A low level of high-density lipoprotein cholesterol (HDL-C) is one of the components of the metabolic syndrome, and has attracted the attention of many physicians as a risk factor for coronary artery disease (CAD). Previous studies have failed to fully characterize the HDL-C profile of elderly patients with CAD. In April 2005, the Japanese Society of Internal Medicine recommended that an HDL-C level <40 mg/ dL should be one of the diagnostic criteria for metabolic syndrome in both Japanese men and women (1). HDL-C levels are normally higher in women than in men and generally decrease with age. In women, the incidence of CAD increases during the postmenopausal period. Some meaningful data have been obtained in Caucasians on the role of a low
F i g u r e 1 . L e v e l s o f t o t a l c h o l e s t e r o l ( T C) a n d l o w-d e n s i t y l i p o p r o t e i n c h o l e s t e r o l ( L DL -C) ( me a n ± 1 S D) i n wo me n a n d me n . T h e r e we r e n o s i g n i f i c a n t d i f f e r e n c e s b e t we e n wo me n a n d me n wi t h r e s p e c t t o t h e T C o r L DL -C l e v e l s .
F i g u r e 2 . L e v e l s o f h i g h -d e n s i t y l i p o p r o t e i n c h o l e s t e r o l ( HDL -C) a n d t r i g l y c e r i d e s ( T G) ( me a n ± 1 S D) i n wo me n a n d me n . T h e HDL -C l e v e l wa s s i g n i f i c a n t l y h i g h e r i n wo me n t h a n i n me n . T h e r e wa s n o s i g n i f i c a n t d i f f e r e n c e b e t we e n wo me n a n d me n wi t h r e s p e c t t o T G.
T (2) , but few studies have addressed this issue in Japanese women. Accordingly, the purpose of this study was to investigate the gender difference of the HDL-C profile in elderly Japanese patients with CAD, especially postmenopausal women.
HDL-C level in the increase of CAD in postmenopausal women
Patients and Methods
The study involved 163 ( me a n ± 1 S D) i n wo me n a n d me n . T h e r e we r e n o s i g n i f i c a n t d i f f e r e n c e s b e t we e n wo me n a n d me n f o r e i t h e r HDL s u b c l a s s .
F i g u r e 4 . L e v e l s o f HDL -C ( me a n ± 1 S D) i n wo me n a n d me n t r e a t e
d ( me d i c a t i o n [ + ] ) o r n o t t r e a t e d ( me d i c a t i o n [ -] )
wi t h a l i p i d -l o we r i n g a g e n t . T h e HDL -C l e v e l o f u n t r e a t e d wo me n wa s s i g n i f i c a n t l y h i g h e r t h a n t h a t o f e i t h e r t r e a t e d o r u n t r e a t e d me n .
F i g u r e 5 . HDL -C l e v e l s ( me a n ± 1 S D) i n wo me n a n d me n p e r f o r mi n g ( e x e r c i s e [ + ] ) o r n o t p e r f o r mi n g ( e x e r c i s e [ -] ) r e g u l a r e x e r c i s e . T h e HDL -C l e v e l o f wo me n p e r f o r mi n g r e g u l a r e x e r c i s e wa s s i g n i f i c a n t l y h i g h e r t h a n t h a t o f me n wi t h o r wi t h o u t r e g u l a r e x e r c i s e . Fig. 3 ). (Fig. 4) (Fig. 5) . 
When analyzed with regard to oral lipid-lowering therapy, the HDL-C level was similar between treated and untreated women (56.8±18.3 vs. 62.2±17.9 mg/dL), as well as between treated and untreated men (50.2±12.4 vs. 50.4±14.8 mg/dL). However, the HDL-C level of untreated women was significantly higher than that of either treated or untreated men
Discussion
Because of the established antiatherosclerotic effect of HDL-C (4-6), the level of this lipoprotein is thought to
Limitations
This was a retrospective observational study performed in a small number of elderly patients who were being treated for CAD. To more fully define the effects of exercise and lipid-lowering therapy on the HDL-C level, it is necessary to perform a large-scale prospective randomized controlled study that compares non-pharmacologic and pharmacologic interventions.
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